ADVINUS THERAPEUTICS LIMITED
Patent Owner
Stats
- 9 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Dec 21, 2017 most recent publication
Details
- 9 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 102 Total Citation Count
- Jun 05, 2008 Earliest Filing
- 0 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9682953 Amide compounds, compositions and applications thereofSep 21, 12Jun 20, 17[A61K, C07F, C07D]
9593115 Substituted fused tricyclic compounds, compositions, and medicinal applications thereofSep 18, 13Mar 14, 17[A61K, C07D]
9550793 Spirocyclic compounds, compositions and medicinal applications thereofOct 01, 13Jan 24, 17[A61K, C07D]
9340506 Acetamide derivatives as glucokinase activators, their process and medicinal applicationsFeb 17, 12May 17, 16[A61K, C07D]
9233983 Substituted hetero-bicyclic compounds, compositions and medicinal applications thereofOct 08, 14Jan 12, 16[A61K, C07D]
9115133 Substituted fused tricyclic compounds, compositions and medicinal applications thereofMar 21, 12Aug 25, 15[A61K, C07D]
9006177 Fused tricyclic compounds as adenosine receptor antagonistSep 22, 11Apr 14, 15[A61K, C07D, A61P]
8796290 Substituted fused pyrimidine compounds, its preparation and uses thereofNov 09, 10Aug 05, 14[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
- No Patents to Display
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.